1. Mastocytosis by minor criteria

   • Eric McGinnis
   • Habib Moshref Razavi

   Images in Hematology 08 November 2019 Pages: 1 - 2

   

2. Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemia

   • Nicolas Duployez
   • Claire Bories

   Images in Hematology 12 November 2019 Pages: 3 - 4

   

3. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-4. Mantle cell lymphoma (MCL)

   • Masataka Okamoto
   • Shigeru Kusumoto

   Guideline 10 December 2019 Pages: 5 - 15

   

4. Current progress and future direction in the treatment for hemophilia

   • Midori Shima

   Progress in Hematology 07 December 2019 Pages: 16 - 19

5. Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity

   • Takehisa Kitazawa
   • Midori Shima

   Progress in Hematology 22 October 2018 Pages: 20 - 30

   

6. Advances in gene therapy for hemophilia: basis, current status, and future perspectives

   • Tsukasa Ohmori

   Progress in Hematology 06 August 2018 Pages: 31 - 41

   

7. Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia

   • Pratima Chowdary

   Progress in Hematology 09 October 2018 Pages: 42 - 50

8. Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate

   • Tomoki Togashi
   • Satomi Nagaya
   • Eriko Morishita

   Original Article 30 October 2019 Pages: 51 - 56

   

9. Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma

   • Isamu Sugiura
   • Kenshi Suzuki
   • Shinsuke Iida

   Original Article 29 October 2019 Pages: 57 - 64

   

10. Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

    • Kohmei Kubo
    • Mitsuo Hori
    • Naoki Takezako

    Original Article 07 November 2019 Pages: 65 - 74

    

11. Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma

    • Yosuke Matsumoto
    • Yoshiaki Chinen
    • Masafumi Taniwaki

    Original Article 04 November 2019 Pages: 75 - 83

    

12. Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning

    • Seitaro Terakura
    • Makoto Onizuka
    • The Nagoya Blood and Marrow Transplantation Group

    Original Article 25 September 2019 Pages: 84 - 92

    

13. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

    • Masamitsu Yanada
    • Akiyoshi Takami
    • Shingo Yano

    Original Article 14 October 2019 Pages: 93 - 102

    

14. Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis

    • Kazuhito Suzuki
    • Nobuhiro Tsukada
    • Kenshi Suzuki

    Original Article 30 October 2019 Pages: 103 - 111

    

15. Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation

    • Sonoko Kamoshita
    • Makoto Murata
    • Hitoshi Kiyoi

    Original Article 26 September 2019 Pages: 112 - 119

    

16. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation

    • Ayumu Ito
    • Shigehisa Kitano
    • Shinichiro Okamoto

    Original Article 22 October 2019 Pages: 120 - 130

    

17. Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis

    • Motoshi Sonoda
    • Masataka Ishimura
    • Shouichi Ohga

    Original Article 23 September 2019 Pages: 131 - 136

    

18. Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis

    • Kazuko Kudo
    • Miho Maeda
    • The Histiocytosis study group of the Japanese Society of Pediatric Hematology/Oncology

    Original Article 22 November 2019 Pages: 137 - 148

    

19. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D−− phenotype

    • Kazuya Mimura
    • Masayuki Endo
    • Tadashi Kimura

    Case Report 19 September 2019 Pages: 149 - 154

    

20. 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome

    • Yasufumi Masaki
    • Hiroshi Kawabata
    • Japanese TAFRO Syndrome Research Team

    Letter to the Editor 28 November 2019 Pages: 155 - 158

21. Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning

    • Seitaro Terakura
    • Makoto Onizuka
    • The Nagoya Blood and Marrow Transplantation Group

    Correction 26 November 2019 Pages: 159 - 160